Metoprolol Succinate Sustained Release Tablets IP

Metoprolol Succinate Sustained Release Tablets IP Specification

Origin of Medicine
India

Drug Type
General Medicines

Physical Form
Capsules

Dosage Guidelines
As Suggested

Suitable For
Adults

Storage Instructions
Cool Place

Metoprolol Succinate Sustained Release Tablets IP Trade Information

Minimum Order Quantity
300 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Metoprolol Succinate Sustained Release Tablets IP

Metoprolol Succinate Sustained Release Tablets IP are highly recommended for managing hypertension and various heart conditions. Manufactured in India, these potent tablets ensure excellent efficacy and reliability. Suitable for adults, these general medicines must be stored in a cool place for maximum shelf life. The dazzling blend of affordability and superior quality makes them a preferred choice among healthcare professionals. Instant checkout is available for bulk and retail buyers alike through our platform, as we operate as a distributor, manufacturer, supplier, and trader across India.

Application, Directions, and Commercial Uses

Metoprolol Succinate Sustained Release Tablets IP are widely utilized for the management of hypertension, angina, and heart failure. These tablets should be used strictly as suggested by a healthcare professional. They are suitable for adult patients requiring ongoing cardiovascular management. The tablets are extensively supplied to hospitals, clinics, and pharmacies, making them ideal for both individual and commercial use within the healthcare industry.

Certifications, Samples, and Packaging Excellence

Our Metoprolol Succinate Sustained Release Tablets IP come with all necessary certifications to assure compliance and safety. Samples are available upon request for quality evaluation, enhancing confidence in the product. We offer premium packaging solutions to ensure freshness and stability during transit. Products are dispatched via a reputable FOB port, and a competitive sale price structure is maintained to support both small and large-scale orders.

FAQ's of Metoprolol Succinate Sustained Release Tablets IP:

Q: How should Metoprolol Succinate Sustained Release Tablets IP be taken for best results?

A: Metoprolol Succinate Sustained Release Tablets IP should be taken as suggested by your healthcare provider, preferably at the same time each day to maintain consistent blood levels. Always follow the dosage guidelines provided.

Q: What are the primary benefits of using Metoprolol Succinate Sustained Release Tablets IP?

A: The primary benefits include effective management of hypertension, reduction of risks associated with angina, and improved heart function in patients with heart failure.

Q: When is it advisable to start Metoprolol Succinate Sustained Release Tablets IP?

A: It is advisable to begin treatment with Metoprolol Succinate SR Tablets IP upon consultation with a medical professional who will determine its necessity based on your specific cardiovascular needs.